Mirum Pharmaceuticals, Inc. <MIRM.O>: RBC cuts target price to $135 from $148
MIRM•Related News
Gold hits seven-week peak as market participants weigh Hormuz reopening prospects
GLD•
Nasdaq trade halt continues <EFTY.O> reason not available at 03:58 AM
EFTY•
Cboe Clear Europe expands SFT clearing into fixed income from Aug. 24
CBOE•
Townsquare net loss widens to $41.8 million in Q2 FY26; revenue totals $115.4 million
TSQ•
Oil gains as investors cautious over Iran-Oman talk progress
XLE•